NCT05716763View on ClinicalTrials.gov

Bioequivalence of IMP 08P1902F0 Relative to Contramal® (100 mg/mL Oral Solution)

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 14, 2023

Primary Completion Date

February 26, 2023

Study Completion Date

February 27, 2023

Conditions
Healthy
Interventions
DRUG

Tramadol Hydrochloride 5 MG/ML Oral Solution

50mg (10mL) single dose

DRUG

Tramadol Hydrochloride 100 MG/ML Oral Solution (Contramal(r))

50mg (20 drops) single dose

Trial Locations (1)

11196

IPRC reserach site facility, Amman

Sponsors
All Listed Sponsors
collaborator

International Pharmaceutical Research Center

OTHER

lead

Unither Pharmaceuticals, France

INDUSTRY

NCT05716763 - Bioequivalence of IMP 08P1902F0 Relative to Contramal® (100 mg/mL Oral Solution) | Biotech Hunter | Biotech Hunter